Odiwac-TZ 281.25 Injection
Marketer
Oddiant Formulations
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Odiwac-TZ 281.25 Injection
Combiflox-TZ 281.25 Injection is a dual-action medication used to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby controlling infection spread. Administration must be overseen by a qualified healthcare provider. Strict adherence to the prescribed dosage schedule is crucial; complete the entire course of treatment, even with symptom improvement. Premature cessation can compromise efficacy. Minor side effects may include nausea, vomiting, diarrhea, or dyspepsia. Report any worsening symptoms to your physician. Seek immediate medical attention for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your doctor about all current medications before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, refrain from driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and ample hydration are vital for optimal recovery. Your doctor may order lab tests to monitor treatment response.
Primary Ingredients of Odiwac-TZ 281.25 Injection
No information provided. Please provide the text you wish to be rewritten.
Uses of Odiwac-TZ 281.25 Injection
Infections caused by bacteria
Major Benefits of Odiwac-TZ 281.25 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Odiwac-TZ 281.25 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Odiwac-TZ 281.25 Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
How Odiwac-TZ 281.25 Injection works:
The injectable formulation Odiwac-TZ 281.25 combines ceftriaxone, a bacterial cell wall synthesis inhibitor antibiotic, with tazobactam, a beta-lactamase inhibitor. Tazobactam's action counteracts bacterial resistance mechanisms, augmenting ceftriaxone's antibacterial efficacy by preserving its ability to disrupt bacterial cell walls.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Odiwac-TZ 281.25 Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Odiwac-TZ 281.25 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The injectable medication Odiwac-TZ 281.25 requires careful consideration when breastfeeding. Mothers should temporarily discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Odiwac-TZ 281.25 Injection can potentially reduce alertness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if any of these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Odiwac-TZ 281.25 Injection to individuals with renal impairment is scarce. Seek medical advice.
LiverCAUTION
Exercise caution when administering Odiwac-TZ 281.25 Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Altering the Odiwac-TZ 281.25 Injection dosage is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Odiwac-TZ 281.25 Injection :
Omitting a scheduled dose of Odiwac-TZ 281.25 Injection warrants immediate physician consultation.
Facts to Know About Odiwac-TZ 281.25 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently